|
|
| |
| Three Brain Pathways That Predict Whether Depression Lifts for Good |
| Depression resists drugs in many. A team at Mount Sinai studied 131 patients who had tried every other option. Each had a tiny electrode placed near a mood center deep in the brain. The method is called deep brain stimulation. |
| Let me explain what they found. Lasting relief did not depend on where the electrode sat. It depended on which white matter pathways, the cables that carry signals between brain regions, the current reached. |
| Three cables mattered. The cingulum bundle links emotion and memory areas. The forceps minor bridges both halves of the prefrontal cortex, the part of the brain where you plan and decide. And the uncinate fasciculus ties the mood center to the fear center. |
| Lasting relief tracked with all three pathways being reached. Those who had not responded after two years had one thing in common: the current missed the left cingulum bundle. That finding now guides the TRANSCEND trial, a controlled test that maps each patient’s own brain wiring before the electrode is placed. |
| |
Across 131 patients in three cohorts, lasting improvement tracked with one pattern: the current reached all three white matter pathways. Patients who had not responded after two years shared one gap: the current missed the left cingulum bundle. |
|
| Ha Neul Song, Ki Sueng Choi, and Helen Mayberg led the analysis. It was a look back at past cases, not a controlled trial. Mayberg consults for the device maker. We are talking about research in progress. But I expect this wiring map to change how doctors treat the worst depression. |
| Ask a doctor about it if someone you know has been through every other treatment. |
| Mount Sinai · American Journal of Psychiatry · October 1, 2026 |
|
|
|
|
| |
| 3,000 Steps a Day to Slow Tau Buildup |
| Walking targets tau, not plaques. Wendy Yau and a team at Mass General Brigham followed 296 adults aged 50 to 90 for over nine years. Each wore a pedometer and had regular cognitive tests. Walking did not clear amyloid, the sticky protein that clumps in Alzheimer’s. But in people who already had those clumps, more steps meant slower tau buildup, the tangled protein that kills neurons. |
| Think of tau like rust on a wire. The plaques are already there. Walking slows the rust. Adults who walked 3,000 to 5,000 steps a day delayed cognitive decline about three years. Those who hit 5,000 to 7,500 delayed it about seven. Gains peaked there. You do not need 10,000. |
| The protocol is simple. |
| The Protocol |
| When |
| Daily, any time of day |
| Duration |
| 30 to 45 minutes at a moderate pace, roughly 3,000 to 5,000 steps a day |
| Rules |
| Start where you are and build up by about 500 steps a week. No special gear needed. Walk outdoors when you can. The strongest gains in the study appeared at 5,000 to 7,500 steps, so 10,000 is not the goal. |
| |
| Watch your energy and your mood over the first two weeks. Most people feel both before any scan would show a change. Start tomorrow morning. |
|
|
|
|
|
|
|
| A Youth Protein Reversed Aging in Brain Immune Cells |
| Your brain has cleanup cells called microglia. Joseph Castellano’s lab at Mount Sinai found that a protein called TIMP2, plentiful in young blood, keeps those cells sharp. When the team removed TIMP2, microglia aged fast and lost the ability to clear debris. When they restored it in older mice, the cells bounced back and inflammation dropped. No one has tested this in people yet. |
| Mount Sinai, Nature Communications · August 2026 |
|
|
| A Drug Restored Myelin in Cells Carrying the Alzheimer’s Risk Gene |
| APOE4 is a risky gene variant. It raises Alzheimer’s odds three- to twelvefold. Li-Huei Tsai at MIT found that it causes oligodendrocytes, the cells that make myelin, to fill up with fat. Myelin is the insulation around your neurons. When it thins, signals slow. A drug that blocks an enzyme called GSK3B cleared the fat and restored myelin in lab cells and in mice. No human trial exists yet. |
| MIT Picower Institute, Cell Stem Cell · October 2026 |
|
|
| A Rare Gene Variant Cut Alzheimer’s Risk 71 Percent |
| A gene variant called APOE4 raises Alzheimer’s risk. Caghan Kizil at Columbia found one reason. APOE4 drives overproduction of a protein called fibronectin around brain blood vessels. That buildup damages the blood-brain barrier, the shield that keeps toxins out. But a rare mutation in the fibronectin gene blocks this process and drops risk 71 percent. In lab models, cutting fibronectin rescued the barrier. No drug has been tested in people. |
| Columbia University, Nature Aging · September 2026 |
|
|
|
|
| Daniel Amen |
| Board-certified psychiatrist and clinical neuroscientist, founder of Amen Clinics, author of Change Your Brain Every Day, 72 years old, has reviewed more than 260,000 brain scans over 30 years |
| He keeps the list specific. Breakfast is eggs with spinach and blueberries. He takes supplements from his own BrainMD line each morning. The stack: a multivitamin called NeuroVite Plus, fish oil at 2 to 4 grams of omega-3 fats, vitamin D3, curcumins, magnesium, and a probiotic. All taken together. He adds ginkgo with vinpocetine, huperzine A, and a saffron extract called Happy Saffron Plus. Caffeine stays at about 100 milligrams a day because he says it constricts blood flow to the brain. No alcohol. He eats six to eight servings of vegetables and fruit each day and takes 10 minutes of morning sunshine. He walks and plays table tennis, which he calls the best brain sport. Sleep is seven to nine hours, with magnesium, L-theanine, or 5-HTP on rough nights. |
| Amen co-founded BrainMD, the company that makes most of his supplements, so treat the list as one man’s informed bet, not an independent prescription. |
|
|
